In vitro Pharmacognostical, Phytochemical and Pharmacological evaluation of Tradescantia spathacea: An exploration

Abstract

Nature has given us a vast array of medicines to treat various chronic and acute illnesses. It is estimated that over 80% of the global population is reliant on traditional medicine for their main health care. Herbal remedies have been used in medicine for thousands of years as a primary treatment in the traditional medical system and have made significant contributions to human health. Since synthetic medicines' toxicity and side effects are now well known, their limits in many therapeutic areas, their relatively expensive cost, and the lack of readily accessible raw pharmaceuticals have all contributed to a surge in worldwide interest in studying and using raw drugs during the last two decades. Because there is a growing interest in herbal medicine throughout the world, the standardization of herbal medicines is the most desired option at this time. Traditional remedies are used by a significant portion of the world's population. As a result, the economic significance of herbal treatments is quickly rising. In addition to a lack of standardization, unethical commercial practices, including adulterating and substituting real herbal drugs, are posing a serious challenge to the general acceptance of tried-and-true herbal-based traditional treatments. The number of pharmaceutical formulations produced by Vaidyas is related to the number of illnesses to be investigated. Tradescantia spathacea (TS) is used to treat a variety of illnesses. TS is an Indian plant that is used as a traditional medicine and belongs to the Commelinaceae family.